Autologous and Allogeneic Methods
Using the latest autologous and allogeneic methods, we help your products meet the exact specifications for patients in a clinical or commercial setting. We also have flexible and cost-effective services for process development and pre-clinical needs.
Cell Therapy Global Network
Our teams of experts at two global sites bring the quality systems background and regulatory experience to help you navigate the important cell therapy product milestones, at any stage of the journey.
Pre-Clinical Through Commercial
We offer industry-leading expertise in process development and internalizing client cell therapy processes, including customization, development, qualification and validation activities for manufacturing and analytics. AGC Biologics’ services support every stage of the product journey, from pre-clinical through commercialization.
Best-in-Class Cell Therapy CDMO services
Offering top-tier cell therapy CDMO services, we excel in every stage of the life cycle, providing comprehensive support from initial development to clinical and commercial manufacturing. We specialize in cell culture and modification. Our capabilities encompass the creation of engineered cells at various scales, backed by analytical method development and qualification.
With a repertoire of over 160 in-house analytical tests thoughtfully designed for clinical and commercial supply, we stand as a comprehensive solution for cell therapy CDMO services.
Have a project in mind?
Outsourcing strategies for allogeneic cell therapy
Learn about strategies for speeding up and optimizing the manufacturing of allogeneic cell therapies.
Creating cost-effective cell therapy programs with NK Cells
As this cell type continues to grow in popularity there are several strategies to consider for building a treatment program.
Download
Cell Media
Strategic partnership with exosome cell manufacturing company RoosterBio to provide the best cell media possible.
